Preview Mode Links will not work in preview mode

Dec 19, 2019

Proceedings from a CME symposium held during the IASLC 2019 North America Conference on Lung Cancer. Featuring perspectives from moderator Dr Joel W Neal and faculty members Drs Nasser H Hanna, Leora Horn and Lecia V Sequist:

  • Introduction (00:00)
  • Evolving Therapeutic Algorithms in Small Cell Lung Cancer (SCLC) (1:04)
  • Optimal Therapeutic Approaches for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (21:55)
  • Management of NSCLC with ALK Rearrangements (35:24)
  • Current and Future Role of Existing and Emerging ROS1 Inhibitors (45:16)
  • Treatment of Metastatic NSCLC with Other Targetable Tumor Mutations (56:06)
  • Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other Systemic Therapies for Metastatic NSCLC (1:15:41)

CME information and select publications